| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| COHEN RAYMOND W | Director | C/O KESTRA MEDICAL TECHNOLOGIES, LTD., 3933 LAKE WASHINGTON BLVD NE, SUITE 200, KIRKLAND | /s/ Traci S. Umberger as attorney-in-fact for Raymond W. Cohen | 08 Sep 2025 | 0001258288 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | KMTS | Common Shares | Purchase | $289,000 | +17,000 | +131% | $17.00 | 29,994 | 07 Mar 2025 | Direct | F1 |
| transaction | KMTS | Common Shares | Award | +10,909 | +36% | 40,903 | 04 Sep 2025 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | The reported securities in this row were purchased in connection with the Issuer's initial public offering reserved share program and were inadvertently omitted from the Reporting Person's prior filings. |
| F2 | The reported securities in this row represent restricted stock units ("RSUs") which each entitle the Reporting Person to receive one common share of the Issuer. The RSUs will vest on September 4, 2026, subject to the Reporting Person's continued service through such date. |